Tirofiban Injection, Solution
Product Images NDC 55150-429

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Tirofiban (NDC 55150-429). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Eugia Us Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Tirofiban-figure-1 (Tirofiban Fig1)

Tirofiban-figure-1 (Tirofiban Fig1)
A line graph titled 'Composite Endpoint 180-Day Follow-Up' comparing the proportion with endpoint over study days between Heparin and Tirofiban Hydrochloride plus Heparin. The graph shows a lower proportion with endpoint for the Tirofiban combination group, indicating 22% risk reduction at around 30 days (p=0.029) and 19% risk reduction at 180 days (p=0.024).*
FDA Label Image

Package Label.principal Display Panel 5 mg Per 100 mL (50 Mcg/ml) (Infusion Bag Label)

Package Label.principal Display Panel 5 mg Per 100 mL (50 Mcg/ml) (Infusion Bag Label)
Label for Tirofiban Hydrochloride Injection 5 mg per 100 mL (50 mcg/mL) solution for intravenous infusion. Premixed, iso-osmotic, sterile, nonpyrogenic, single-dose 100 mL container. Manufactured for Eugia US LLC, includes barcode and NDC 55150-429-01. Storage and usage instructions are also present.*
FDA Label Image

Package Label.principal Display Panel 5 mg Per 100 mL (50 Mcg/ml) (Pouch Label)

Package Label.principal Display Panel 5 mg Per 100 mL (50 Mcg/ml) (Pouch Label)
Label for Tirofiban Hydrochloride Injection 5 mg per 100 mL (50 mcg/mL) solution for intravenous infusion. The label indicates it is a sterile, nonpyrogenic, iso-osmotic, single-dose 100 mL container. It includes usage storage instructions, manufacturer Eugia US LLC, and a barcode.*
FDA Label Image

Package Label.principal Display Panel 5 mg Per 100 mL (50 Mcg/ml) (Container Carton)

Package Label.principal Display Panel 5 mg Per 100 mL (50 Mcg/ml) (Container Carton)
Packaging label for Tirofiban Hydrochloride Injection 5 mg per 100 mL (50 mcg/mL) premixed intravenous infusion solution. The label states the product is sterile, nonpyrogenic, iso-osmotic, and supplied in a 100 mL single-dose container. The labeler is Eugia US LLC, with storage and usage instructions, and the NDC is 55150-429-01.*
FDA Label Image

Package Label.principal Display Panel 12.5 mg Per 250 mL (50 Mcg/ml) (Infusion Bag Label)

Package Label.principal Display Panel 12.5 mg Per 250 mL (50 Mcg/ml) (Infusion Bag Label)
Tirofiban Hydrochloride Injection 12.5 mg per 250 mL (50 mcg/mL) in a sterile, nonpyrogenic, iso-osmotic intravenous solution. The label indicates a 250 mL single-dose container for intravenous infusion, manufactured for Eugia US LLC. Storage and usage instructions are included on the label along with the barcode and NDC 55150-430-01.*
FDA Label Image

Package Label.principal Display Panel 12.5 mg Per 250 mL (50 Mcg/ml) (Pouch Label)

Package Label.principal Display Panel 12.5 mg Per 250 mL (50 Mcg/ml) (Pouch Label)
Label for Tirofiban Hydrochloride Injection 12.5 mg per 250 mL (50 mcg/mL) premixed solution for intravenous infusion. The 250 mL single-dose container is sterile, nonpyrogenic, and iso-osmotic. Manufactured by Eugia US LLC. Includes storage instructions, cautions, and usual dosage guidance.*
FDA Label Image

Package Label.principal Display Panel 12.5 mg Per 250 mL (50 Mcg/ml) (Container Carton)

Package Label.principal Display Panel 12.5 mg Per 250 mL (50 Mcg/ml) (Container Carton)
Tirofiban Hydrochloride Injection 12.5 mg per 250 mL (50 mcg/mL) premixed intravenous infusion solution in a 250 mL single-dose container. The label states it is sterile, nonpyrogenic, iso-osmotic, and intended for use with a calibrated infusion device. Distributed by Eugia US LLC, with storage instructions to protect from light and store between 15° to 30°C.*
FDA Label Image

Chemical-structure (Tirofiban Str)

Chemical-structure (Tirofiban Str)
Chemical structure of the active ingredient Tirofiban, including its hydrochloride and hydrate forms, as depicted in a molecular diagram.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.